Literature DB >> 19588394

Mono and multifaceted inhalant and/or food allergen reduction interventions for preventing asthma in children at high risk of developing asthma.

Tanja Maas1, Janneke Kaper, Aziz Sheikh, J André Knottnerus, Geertjan Wesseling, Edward Dompeling, Jean W M Muris, Constant Paul van Schayck.   

Abstract

BACKGROUND: Allergen exposure is one of the environmental factors seemingly associated with the development of asthma. If asthma is a multi-factorial disease, it is hypothesised that prevention might only prove effective if most or all relevant environmental factors are simultaneously avoided.
OBJECTIVES: To assess effect(s) of monofaceted and multifaceted interventions compared with control interventions in preventing asthma and asthma symptoms in high risk children. SEARCH STRATEGY: We searched the Cochrane Airways Trials Register (December 2008). SELECTION CRITERIA: Randomised controlled trials of allergen exposure reduction for the primary prevention of asthma in children. Interventions were multifaceted (reducing exposure to both inhalant and food allergens) or monofaceted (reducing exposure to either inhalant or food allergens) Follow up had to be from birth (or during pregnancy) up to a minimum of two years of age. DATA COLLECTION AND ANALYSIS: We included in the analysis studies assessing the primary outcome (current diagnosis: asthma) and/or one of the secondary outcomes (current respiratory symptoms: wheezing, nocturnal coughing and dyspnoea). We pooled multifaceted and monofaceted intervention trials separately. We made an indirect comparison of their effects using tests for interaction to calculate relative odds ratios. MAIN
RESULTS: We included three multifaceted and six monofaceted intervention studies (3271 children). Physician diagnosed asthma in children less than five years, and asthma as defined by respiratory symptoms and lung function criteria in children aged five years and older, both favoured treatment with a multifaceted intervention compared to usual care (< 5 years: odds ratio (OR) 0.72, 95% confidence interval (CI) 0.54 to 0.96, and > 5 years: OR 0.52, 95% CI 0.32 to 0.85). However, there was no significant difference in outcome between monofaceted intervention and control interventions (< 5 years: OR 1.12, 95% CI 0.76 to 1.64, and > 5 years: OR 0.83, 95% CI 0.59 to 1.16). Indirect comparison between these treatments did not demonstrate a significant difference between multiple interventions and mono-interventions in reducing the frequency of asthma diagnosis in children under five years (relative OR 0.64 (95% CI 0.40 to 1.04, P = 0.07) or five years and older (relative OR 0.63, 95% CI 0.35 to 1.13, P = 0.12). There was also no significant difference between either mono- and multifaceted intervention and control in reducing the likelihood of symptoms of nocturnal coughing at follow up. Wheezing, however, showed a significant difference between multifaceted and mono-interventions (relative OR 0.59, 95% CI 0.35 to 0.99, P = 0.04), but the significance was lost when data on treatment only was analysed. AUTHORS'
CONCLUSIONS: The available evidence suggests that the reduction of exposure to multiple allergens compared to usual care reduces the likelihood of a current diagnosis of asthma in children (at ages < 5 years and 5 years and older). Mono-intervention studies have not produced effects which are statistically significant compared with control. In children who are at risk of developing childhood asthma, multifaceted interventions, characterised by dietary allergen reduction and environmental remediation, reduce the odds of a physician diagnosis of asthma later in childhood by half. This translates to a number needed to treat (NNT) of 17. The effect of multi-faceted interventions on parent reported wheeze was inconsistent and had no significant impact on nocturnal coughing or dyspnoea. Data from monofaceted intervention exposed children studies were not significantly different from those of control groups for all outcomes. There remains uncertainty as to whether multiple interventions are more effective than mono-component interventions. The comparisons made were indirect, making the conclusions drawn uncertain. To our knowledge there are no ongoing studies in which both intervention strategies are randomly compared. The findings, however, warrant further direct comparison between multiple- and monofaceted interventions aimed at reducing the prevalence of asthma in children.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19588394     DOI: 10.1002/14651858.CD006480.pub2

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  26 in total

Review 1.  School Environmental Intervention Programs.

Authors:  Perdita Permaul; Wanda Phipatanakul
Journal:  J Allergy Clin Immunol Pract       Date:  2018 Jan - Feb

2.  Cost-effectiveness of primary prevention of paediatric asthma: a decision-analytic model.

Authors:  G Feljandro P Ramos; Antoinette D I van Asselt; Sandra Kuiper; Johan L Severens; Tanja Maas; Edward Dompeling; J André Knottnerus; Onno C P van Schayck
Journal:  Eur J Health Econ       Date:  2013-10-06

Review 3.  Practical and Conceptual Considerations for the Primary Prevention of Asthma.

Authors:  Steven M Brunwasser; Tina V Hartert
Journal:  Clin Chest Med       Date:  2018-12-19       Impact factor: 2.878

4.  TGF-β-mediated airway tolerance to allergens induced by peptide-based immunomodulatory mucosal vaccination.

Authors:  H Michael; Y Li; Y Wang; D Xue; J Shan; B D Mazer; C T McCusker
Journal:  Mucosal Immunol       Date:  2015-03-18       Impact factor: 7.313

Review 5.  Housing interventions and control of asthma-related indoor biologic agents: a review of the evidence.

Authors:  James Krieger; David E Jacobs; Peter J Ashley; Andrea Baeder; Ginger L Chew; Dorr Dearborn; H Patricia Hynes; J David Miller; Rebecca Morley; Felicia Rabito; Darryl C Zeldin
Journal:  J Public Health Manag Pract       Date:  2010 Sep-Oct

Review 6.  New insights into the natural history of asthma: primary prevention on the horizon.

Authors:  Fernando D Martinez
Journal:  J Allergy Clin Immunol       Date:  2011-11       Impact factor: 10.793

Review 7.  Developing Primary Intervention Strategies to Prevent Allergic Disease.

Authors:  Kristina Rueter; Aveni Haynes; Susan L Prescott
Journal:  Curr Allergy Asthma Rep       Date:  2015-07       Impact factor: 4.806

8.  Environmental assessment and exposure control: a practice parameter--furry animals.

Authors:  Jay Portnoy; Kevin Kennedy; James Sublett; Wanda Phipatanakul; Elizabeth Matsui; Charles Barnes; Carl Grimes; J David Miller; James M Seltzer; P Brock Williams; Jonathan A Bernstein; David I Bernstein; Joann Blessing-Moore; Linda Cox; David A Khan; David M Lang; Richard A Nicklas; John Oppenheimer
Journal:  Ann Allergy Asthma Immunol       Date:  2012-04       Impact factor: 6.347

9.  Essential oil components from Asarum sieboldii Miquel are toxic to the house dust mite Dermatophagoides farinae.

Authors:  Haiqiang Wu; Jing Li; Fang Zhang; Li Li; Zhigang Liu; Zhendan He
Journal:  Parasitol Res       Date:  2012-07-26       Impact factor: 2.289

10.  Molecular allergology approach to allergic diseases in the paediatric age.

Authors:  Claudia Alessandri; Danila Zennaro; Alessandra Zaffiro; Adriano Mari
Journal:  Ital J Pediatr       Date:  2009-10-05       Impact factor: 2.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.